BIOX · Bioceres Crop Solutions Corp. · Financials
Market Cap
$26.17M
Shares
63.82M
Income-statement, balance-sheet and cash-flow figures from SEC filings, plus a debt profile anchored in the latest 10-K and updated by each 10-Q and debt exhibit.
Revenue
$335.11M
-27.9%
FY2025
Net Income
-$55.42M
-1396.1%
FY2025
Gross Margin
39.3%
-0.8pp
FY2025
Operating Margin
-0.67%
-10.5pp
FY2025
Diluted EPS
-$0.88
-1402.2%
FY2025
Operating Cash Flow
$49.91M
+19.6%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|---|
| $294.42M | $335.11M | $464.78M | $420.06M | $334.84M | $209.53M | $173.09M | $160.61M | $133.54M | |
| $178.82M | $203.42M | $278.22M | $235.46M | $208.36M | $118.64M | $93.58M | $86.96M | $77.09M | |
| $115.6M | $131.68M | $186.56M | $184.6M | $126.48M | $90.88M | $79.52M | $73.64M | $56.45M | |
| — | 39.3% | 40.14% | 43.95% | 37.77% | 43.38% | 45.94% | 45.85% | 42.27% | |
| $16.6M | $14.91M | $17.18M | $15.35M | $6.95M | $5.62M | $4.2M | $3.69M | $3.95M | |
| — | — | — | — | — | $680.94K | $359K | $383.56K | $567.15K | |
| $5.82M | $5.99M | $5.76M | $4.83M | $3.77M | $3.05M | $2.01M | $2.45M | $2.23M | |
| -$4.24M | -$2.24M | $45.85M | $54.18M | $39.87M | $38.38M | $39.15M | $32.09M | $15.71M | |
| — | -0.67% | 9.87% | 12.9% | 11.91% | 18.32% | 22.62% | 19.98% | 11.76% | |
| $1.58M | $3.75M | $51.62M | $59.02M | $43.64M | $41.43M | $41.16M | $34.54M | $17.94M | |
| $32.31M | $28.84M | $26.87M | $23.79M | $17.93M | $21.24M | $20.88M | $23.41M | $17.19M | |
| -$64.14M | -$57.57M | $11.07M | $19.11M | $14.06M | $10.53M | $6.44M | -$9.37M | -$25.24M | |
| $7.1M | $1.27M | $3.78M | -$1.07M | $17.97M | $14.35M | $2.21M | $6.99M | -$10.93M | |
| -$239.45M | -$55.42M | $4.28M | $18.78M | -$7.2M | -$6.87M | $3.36M | -$18.37M | -$11.04M | |
| — | -16.54% | 0.92% | 4.47% | -2.15% | -3.28% | 1.94% | -11.44% | -8.27% | |
| USD/shares | -$3.78 | -$0.88 | $0.07 | $0.30 | -$0.17 | -$0.18 | $0.09 | -$0.60 | -$0.39 |
| USD/shares | -$3.78 | -$0.88 | $0.07 | $0.30 | -$0.17 | -$0.18 | $0.09 | -$0.60 | -$0.39 |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.
Capital Returned to Shareholders
Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2019–FY2025: $8.19M in buybacks, $712.77K in dividends.
Debt Profile
No verified debt profile is available yet. This does not establish that the company has no debt or covenants.
Key facts
CIK
1769484
CUSIP
G1117K114
13F (30d)
19 filings
19 filers
Visit website
Investor relations